PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 913474
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 913474
Abstract:
Global Patient Derived Xenograft/PDX Models Market to Reach $294.7 Million by 2027
Amid the COVID-19 crisis, the global market for Patient Derived Xenograft/PDX Models estimated at US$102.7 Million in the year 2020, is projected to reach a revised size of US$294.7 Million by 2027, growing at aCAGR of 16.3% over the period 2020-2027. Mouse, one of the segments analyzed in the report, is projected to record 15.3% CAGR and reach US$197.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Rat segment is readjusted to a revised 18.4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $30.4 Million, While China is Forecast to Grow at 15.7% CAGR
The Patient Derived Xenograft/PDX Models market in the U.S. is estimated at US$30.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$51.2 Million by the year 2027 trailing a CAGR of 15.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.5% and 14% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 11.9% CAGR.
Select Competitors (Total 38 Featured) -